Improvements in Patient-Reported Outcomes After 12 Months of Maintenance Therapy With Cabotegravir + Rilpivirine Long-Acting Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide in the Phase 3b SOLAR Study
Titel:
Improvements in Patient-Reported Outcomes After 12 Months of Maintenance Therapy With Cabotegravir + Rilpivirine Long-Acting Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide in the Phase 3b SOLAR Study
Auteur:
Mussini, Cristina Cazanave, Charles Adachi, Eisuke Eu, Beng Alonso, Marta Montero Crofoot, Gordon Chounta, Vasiliki Kolobova, Irina Sutton, Kenneth Sutherland-Phillips, Denise Urbaityte, Rimgaile Ehmann, Alice Scherzer, Jenny de los Rios, Patricia D’Amico, Ronald Spreen, William van Wyk, Jean